AXIO | Proficiency Testing schemes 2026
Immunosuppressants IPT
“For laboratories that quantify immunosuppressant drugs in blood and plasma” Immunosuppressant drugs are a class of drugs that suppress, or reduce, the response of the body’s immune system. In addition to being used to prevent organ rejection, they are often used to treat autoimmune disorders such as lupus, psoriasis and rheumatoid arthritis. Regular blood tests are essential for monitoring therapeutic levels and whether dosage changes are needed. To successfully make these informed decisions, laboratories need to demonstrate that drug measurements are reliable, reproducible and accurate. The AXIO Proficiency Testing Immunosuppressant Scheme (IPT) provides independent performance assessment for laboratories quantifying immunosuppressant drugs in blood and plasma. The operation of our AXIO IPT scheme is supported by an Advisory Group consisting of members of professional bodies, scheme participants, and others experienced in the field. The scheme reports on the performance of UK participants (who have clinical responsibilities) to the National Quality Assurance Advisory Panels for Chemical Pathology.
Download Application Form
Download Scheme Description
The full range and availability of test materials and analytes is determined on an annual basis and may be added or removed. For accredited and non-accredited status, plus the most up to date sample data, please see the current application form/scheme description for this scheme.
102 lgcstandards.com/AXIO
Made with FlippingBook - professional solution for displaying marketing and sales documents online